Results per Page:
A niche topic: understanding the development of hematopoietic stem cells
From the Hadland and Bernstein labs, Translational Science and Therapeutics Division
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Holding the line: low CpG content and DNA inaccessibility safeguard T cell commitment
From the Bernstein Lab, Clinical Research Division
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia
Hutch-based repository leads to lifesaving treatments for young cancer patient
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies
New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
Meeting someone who saved your life
Bone marrow transplant recipient and reunion volunteer shares story of meeting her donor
Remembering Fred Hutch's Dr. Harold Weintraub 20 years later
20 years after Dr. Harold Weintraub’s death, his life — and his research — are still making a difference
Two Hutchinson Center researchers receive prestigious awards from Damon Runyon Cancer Research Foundation
Drs. Brian Till and Colleen Delaney will use the awards for immunotherapy research
Bench-to-bedside success story
Early clinical trial successes show the amazing, lifesaving potential of Colleen Delaney's unique umbilical cord-blood transplant program
Fred Hutchinson Research Center Awarded $7 Million Grant to Lead Cancer Research Initiative
Investigation is part of the Leukemia & Lymphoma Society's $52 million global research program that seeks to find cures for blood cancers